glp-1 agonist medications for Weight Loss: Semaglutide vs Tirzepatide vs Retat – Revolution Health & Wellness Comparing Ozempic, Wegovy and Other
Description
doi: 10.1001/JAMA.2023.13872
Kruse, T
No funding was received to assist with the preparation of this manuscript
Early trials, concerned about possible cardiac safety issues, were designed to ensure that GLP-1 use did not negatively impact cardiovascular outcomes
Louis truck accident lawyers
Furthermore, compared to dulaglutide, tirzepatide at a dose of 0.75 mg once weekly was more effective at controlling blood glucose levels in this cohort
